Incyte to Present at Upcoming Investor Conference

Audio By Carbonatix

WILMINGTON, Del.--(BUSINESS WIRE)--Dec 18, 2025--

Incyte (Nasdaq:INCY) announced today that it will present at the 44 th Annual J. P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 am (PST).

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251218287907/en/

CONTACT: Incyte ContactsMedia

[email protected]

[email protected]

KEYWORD: DELAWARE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Incyte

Copyright Business Wire 2025.

PUB: 12/18/2025 08:00 AM/DISC: 12/18/2025 08:03 AM

http://www.businesswire.com/news/home/20251218287907/en